Cecil Haney Sells 1,300 Shares of Tenet Healthcare (NYSE:THC) Stock

Tenet Healthcare Corporation (NYSE:THC) Director Cecil Haney sold 1,300 shares of the stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $278.03, for a total transaction of $361,439.00. Following the completion of the transaction, the director directly owned 12,553 shares of the company’s stock, valued at approximately $3,490,110.59. The trade was a 9.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Tenet Healthcare Stock Performance

Tenet Healthcare stock opened at $267.61 on Friday. Tenet Healthcare Corporation has a fifty-two week low of $157.58 and a fifty-two week high of $283.05. The stock’s 50 day simple moving average is $228.11 and its two-hundred day simple moving average is $209.12. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. The stock has a market cap of $21.55 billion, a price-to-earnings ratio of 10.32, a PEG ratio of 1.05 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm had revenue of $6.04 billion during the quarter, compared to analyst estimates of $5.43 billion. During the same quarter in the prior year, the company earned $4.02 EPS. The business’s revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, analysts expect that Tenet Healthcare Corporation will post 20.98 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on THC shares. KeyCorp decreased their price target on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Guggenheim upped their price objective on shares of Tenet Healthcare from $242.00 to $283.00 and gave the stock a “buy” rating in a report on Tuesday, July 28th. Robert W. Baird lifted their target price on shares of Tenet Healthcare from $210.00 to $280.00 and gave the company a “neutral” rating in a report on Tuesday, July 28th. The Goldman Sachs Group restated a “buy” rating and issued a $305.00 price target on shares of Tenet Healthcare in a research note on Tuesday, July 28th. Finally, Stephens reiterated an “overweight” rating and set a $285.00 price objective on shares of Tenet Healthcare in a research note on Monday, July 27th. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and an average price target of $273.00.

Hedge Funds Weigh In On Tenet Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Tenet Healthcare in the 2nd quarter worth $5,504,000. California State Teachers Retirement System lifted its holdings in shares of Tenet Healthcare by 18,362.2% during the second quarter. California State Teachers Retirement System now owns 18,885,726 shares of the company’s stock valued at $3,533,142,000 after purchasing an additional 18,783,432 shares in the last quarter. Compass Financial Management LLC purchased a new stake in shares of Tenet Healthcare during the second quarter valued at $57,000. AlphaGrep UK Ltd bought a new stake in Tenet Healthcare in the 2nd quarter worth about $344,000. Finally, BAM Wealth Management LLC lifted its stake in Tenet Healthcare by 73.1% during the 2nd quarter. BAM Wealth Management LLC now owns 2,421 shares of the company’s stock valued at $453,000 after acquiring an additional 1,022 shares during the period. 95.44% of the stock is owned by institutional investors.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.